Home » Analyst Articles – US
lululemon athletica (NASDAQ:LULU) Price Target Cut to $175.00 by Analysts at Telsey Advisory Group
lululemon athletica (NASDAQ:LULU – Free Report) had its price target trimmed by Telsey Advisory Group from $215.00 to $175.00 in a report issued on Wednesday, MarketBeat reports. The firm currently has a market perform rating... More of this article »
Docusign (NASDAQ:DOCU) Price Target Cut to $55.00 by Analysts at Robert W. Baird
Docusign (NASDAQ:DOCU – Free Report) had its price target reduced by Robert W. Baird from $75.00 to $55.00 in a report issued on Wednesday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the stock. Other... More of this article »
lululemon athletica (NASDAQ:LULU) Given New $225.00 Price Target at BTIG Research
lululemon athletica (NASDAQ:LULU – Free Report) had its price target decreased by BTIG Research from $250.00 to $225.00 in a research note published on Wednesday morning, Marketbeat reports. BTIG Research currently has a buy... More of this article »
Docusign (NASDAQ:DOCU) Given New $86.00 Price Target at Citizens Jmp
Docusign (NASDAQ:DOCU – Free Report) had its price target decreased by Citizens Jmp from $124.00 to $86.00 in a research report sent to investors on Wednesday morning,Benzinga reports. Citizens Jmp currently has a market outperform... More of this article »
lululemon athletica (NASDAQ:LULU) Price Target Lowered to $190.00 at Robert W. Baird
lululemon athletica (NASDAQ:LULU – Free Report) had its price objective decreased by Robert W. Baird from $210.00 to $190.00 in a report issued on Wednesday morning,Benzinga reports. Robert W. Baird currently has a neutral rating... More of this article »
Docusign (NASDAQ:DOCU) Given “Buy” Rating at BTIG Research
BTIG Research restated their buy rating on shares of Docusign (NASDAQ:DOCU – Free Report) in a research report report published on Wednesday,Benzinga reports. BTIG Research currently has a $70.00 price target on the stock. A... More of this article »
Netflix (NASDAQ:NFLX) Now Covered by Analysts at Citigroup
Citigroup started coverage on shares of Netflix (NASDAQ:NFLX – Free Report) in a research note released on Wednesday morning, Marketbeat reports. The firm issued a buy rating and a $115.00 target price on the Internet television... More of this article »
lululemon athletica (NASDAQ:LULU) Given New $150.00 Price Target at Wells Fargo & Company
lululemon athletica (NASDAQ:LULU – Free Report) had its target price reduced by Wells Fargo & Company from $175.00 to $150.00 in a research report report published on Wednesday morning,Benzinga reports. Wells Fargo &... More of this article »
Sanford C. Bernstein Issues Positive Forecast for Micron Technology (NASDAQ:MU) Stock Price
Micron Technology (NASDAQ:MU – Free Report) had its target price hoisted by Sanford C. Bernstein from $330.00 to $510.00 in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have an outperform... More of this article »
Docusign (NASDAQ:DOCU) Price Target Cut to $60.00 by Analysts at Wells Fargo & Company
Docusign (NASDAQ:DOCU – Free Report) had its target price decreased by Wells Fargo & Company from $75.00 to $60.00 in a report released on Wednesday,Benzinga reports. Wells Fargo & Company currently has an equal weight... More of this article »
Ecolab (NYSE:ECL) Price Target Cut to $285.00 by Analysts at Wells Fargo & Company
Ecolab (NYSE:ECL – Free Report) had its target price trimmed by Wells Fargo & Company from $310.00 to $285.00 in a research report released on Wednesday,Benzinga reports. The firm currently has an equal weight rating on... More of this article »
CF Industries (NYSE:CF) Price Target Raised to $140.00 at BMO Capital Markets
CF Industries (NYSE:CF – Free Report) had its price objective hoisted by BMO Capital Markets from $115.00 to $140.00 in a research note released on Wednesday,Benzinga reports. BMO Capital Markets currently has an outperform rating... More of this article »
CervoMed (NASDAQ:CRVO) Price Target Raised to $21.00 at Chardan Capital
CervoMed (NASDAQ:CRVO – Free Report) had its price target upped by Chardan Capital from $15.00 to $21.00 in a report issued on Wednesday,Benzinga reports. Chardan Capital currently has a buy rating on the stock. A number of other... More of this article »
Lumentum’s (LITE) “Buy” Rating Reaffirmed at Rosenblatt Securities
Rosenblatt Securities reaffirmed their buy rating on shares of Lumentum (NASDAQ:LITE – Free Report) in a report published on Wednesday,Benzinga reports. Rosenblatt Securities currently has a $900.00 price target on the technology... More of this article »
Bicycle Therapeutics (NASDAQ:BCYC) Given New $15.00 Price Target at Needham & Company LLC
Bicycle Therapeutics (NASDAQ:BCYC – Free Report) had its price objective lowered by Needham & Company LLC from $24.00 to $15.00 in a research report released on Wednesday morning,Benzinga reports. The firm currently has... More of this article »
CytomX Therapeutics (NASDAQ:CTMX) Given New $15.00 Price Target at Guggenheim
CytomX Therapeutics (NASDAQ:CTMX – Free Report) had its price objective increased by Guggenheim from $10.00 to $15.00 in a report issued on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the biotechnology... More of this article »
Academy Sports and Outdoors (NASDAQ:ASO) Given New $52.00 Price Target at Wells Fargo & Company
Academy Sports and Outdoors (NASDAQ:ASO – Free Report) had its price objective reduced by Wells Fargo & Company from $57.00 to $52.00 in a report issued on Wednesday,Benzinga reports. They currently have an equal weight... More of this article »
Dorman Products’ (DORM) Overweight Rating Reaffirmed at Stephens
Stephens reaffirmed their overweight rating on shares of Dorman Products (NASDAQ:DORM – Free Report) in a report issued on Wednesday,Benzinga reports. The brokerage currently has a $150.00 target price on the auto parts company’s... More of this article »
Fold (NASDAQ:FLD) Given New $2.00 Price Target at Cantor Fitzgerald
Fold (NASDAQ:FLD – Free Report) had its target price cut by Cantor Fitzgerald from $4.50 to $2.00 in a report released on Wednesday,Benzinga reports. They currently have an overweight rating on the stock. FLD has been the topic... More of this article »
Bicycle Therapeutics (NASDAQ:BCYC) Price Target Lowered to $8.00 at Citizens Jmp
Bicycle Therapeutics (NASDAQ:BCYC – Free Report) had its price objective decreased by Citizens Jmp from $12.00 to $8.00 in a research report sent to investors on Wednesday morning,Benzinga reports. Citizens Jmp currently has... More of this article »
Lucid Group (NASDAQ:LCID) Now Covered by Citigroup
Citigroup initiated coverage on shares of Lucid Group (NASDAQ:LCID – Free Report) in a report published on Wednesday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $17.00 target price on the stock. Several... More of this article »
Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Lowered to $27.00 at The Goldman Sachs Group
Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) had its price target cut by The Goldman Sachs Group from $38.00 to $27.00 in a research note published on Wednesday,Benzinga reports. They currently have a buy rating on the stock. Other... More of this article »
Academy Sports and Outdoors (NASDAQ:ASO) Given New $49.00 Price Target at Barclays
Academy Sports and Outdoors (NASDAQ:ASO – Free Report) had its price target trimmed by Barclays from $59.00 to $49.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an equal weight rating on the... More of this article »
Gemini Space Station (NASDAQ:GEMI) Downgraded by Citigroup to Sell
Citigroup lowered shares of Gemini Space Station (NASDAQ:GEMI – Free Report) from a neutral rating to a sell rating in a research report sent to investors on Wednesday morning, MarketBeat Ratings reports. They currently have... More of this article »
lululemon athletica (NASDAQ:LULU) Price Target Lowered to $161.00 at Barclays
lululemon athletica (NASDAQ:LULU – Free Report) had its price objective decreased by Barclays from $203.00 to $161.00 in a research note released on Wednesday morning,Benzinga reports. Barclays currently has an equal weight rating... More of this article »
Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Cut to $31.00 by Analysts at Cantor Fitzgerald
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its price target cut by Cantor Fitzgerald from $35.00 to $31.00 in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have an overweight... More of this article »
HealthEquity (NASDAQ:HQY) Price Target Lowered to $123.00 at JPMorgan Chase & Co.
HealthEquity (NASDAQ:HQY – Free Report) had its target price lowered by JPMorgan Chase & Co. from $129.00 to $123.00 in a report released on Wednesday morning,Benzinga reports. The firm currently has an overweight rating... More of this article »
B. Riley Financial Issues Positive Forecast for Perpetua Resources (NASDAQ:PPTA) Stock Price
Perpetua Resources (NASDAQ:PPTA – Free Report) had its price target hoisted by B. Riley Financial from $30.00 to $40.00 in a report released on Wednesday morning,Benzinga reports. B. Riley Financial currently has a buy rating... More of this article »
Harrow (NASDAQ:HROW) Given Buy Rating at BTIG Research
BTIG Research reissued their buy rating on shares of Harrow (NASDAQ:HROW – Free Report) in a research report released on Wednesday, MarketBeat Ratings reports. BTIG Research currently has a $63.00 price target on the stock. Several... More of this article »
lululemon athletica (NASDAQ:LULU) Price Target Lowered to $176.00 at UBS Group
lululemon athletica (NASDAQ:LULU – Free Report) had its target price lowered by UBS Group from $189.00 to $176.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has a neutral rating on the apparel retailer’s... More of this article »
lululemon athletica (NASDAQ:LULU) Given New $176.00 Price Target at Stifel Nicolaus
lululemon athletica (NASDAQ:LULU – Free Report) had its target price cut by Stifel Nicolaus from $210.00 to $176.00 in a research report report published on Wednesday,Benzinga reports. They currently have a hold rating on the... More of this article »
Docusign (NASDAQ:DOCU) Price Target Lowered to $54.00 at UBS Group
Docusign (NASDAQ:DOCU – Free Report) had its price target decreased by UBS Group from $75.00 to $54.00 in a research report report published on Wednesday,Benzinga reports. UBS Group currently has a neutral rating on the stock. Several... More of this article »
Jabil (NYSE:JBL) Price Target Raised to $304.00 at Barclays
Jabil (NYSE:JBL – Free Report) had its price target boosted by Barclays from $283.00 to $304.00 in a research note published on Wednesday,Benzinga reports. The firm currently has an overweight rating on the technology company’s... More of this article »
Lennar (NYSE:LEN) Price Target Cut to $105.00 by Analysts at Keefe, Bruyette & Woods
Lennar (NYSE:LEN – Free Report) had its price target trimmed by Keefe, Bruyette & Woods from $115.00 to $105.00 in a research note published on Wednesday morning,Benzinga reports. The brokerage currently has a market perform... More of this article »
Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded to “Buy” at Maxim Group
Maxim Group upgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Wednesday morning, MarketBeat reports. The brokerage currently has... More of this article »
BrightSpring Health Services (NASDAQ:BTSG) Given New $55.00 Price Target at UBS Group
BrightSpring Health Services (NASDAQ:BTSG – Free Report) had its price objective increased by UBS Group from $53.00 to $55.00 in a report published on Wednesday,Benzinga reports. They currently have a buy rating on the stock. Other... More of this article »
Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Lowered to $100.00 at HC Wainwright
Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its target price lowered by HC Wainwright from $110.00 to $100.00 in a report issued on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the... More of this article »
Lineage (NASDAQ:LINE) Now Covered by Compass Point
Compass Point initiated coverage on shares of Lineage (NASDAQ:LINE – Free Report) in a report published on Wednesday, MarketBeat reports. The firm issued a buy rating and a $47.00 price target on the stock. Other equities analysts... More of this article »
G-III Apparel Group (NASDAQ:GIII) Receives “Buy” Rating from BTIG Research
BTIG Research restated their buy rating on shares of G-III Apparel Group (NASDAQ:GIII – Free Report) in a report issued on Wednesday morning, MarketBeat Ratings reports. They currently have a $34.00 price objective on the textile... More of this article »
XCF Global Capital (NASDAQ:SAFX) Now Covered by Roth Mkm
Roth Mkm initiated coverage on shares of XCF Global Capital (NASDAQ:SAFX – Free Report) in a research report sent to investors on Wednesday, Marketbeat Ratings reports. The firm issued a neutral rating and a $0.40 price target... More of this article »
Bitdeer Technologies Group (NASDAQ:BTDR) Receives Buy Rating from Rosenblatt Securities
Rosenblatt Securities reiterated their buy rating on shares of Bitdeer Technologies Group (NASDAQ:BTDR – Free Report) in a report published on Wednesday morning,Benzinga reports. They currently have a $18.00 price target on... More of this article »
BrightSpring Health Services (NASDAQ:BTSG) Given New $52.00 Price Target at Mizuho
BrightSpring Health Services (NASDAQ:BTSG – Free Report) had its price target boosted by Mizuho from $50.00 to $52.00 in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have an outperform... More of this article »
Monte Rosa Therapeutics (NASDAQ:GLUE) Price Target Lowered to $29.00 at Wells Fargo & Company
Monte Rosa Therapeutics (NASDAQ:GLUE – Free Report) had its price objective decreased by Wells Fargo & Company from $30.00 to $29.00 in a research note released on Wednesday,Benzinga reports. Wells Fargo & Company currently... More of this article »
iBio (NASDAQ:IBIO) Receives Buy Rating from Chardan Capital
Chardan Capital reissued their buy rating on shares of iBio (NASDAQ:IBIO – Free Report) in a research note released on Wednesday,Benzinga reports. The brokerage currently has a $5.00 price target on the stock. IBIO has been... More of this article »
Health Catalyst’s (HCAT) Equal Weight Rating Reaffirmed at Wells Fargo & Company
Wells Fargo & Company reiterated their equal weight rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a report issued on Wednesday morning, MarketBeat reports. They currently have a $1.00 price target on... More of this article »
Kestra Medical Technologies (NASDAQ:KMTS) Given Buy Rating at BTIG Research
BTIG Research reaffirmed their buy rating on shares of Kestra Medical Technologies (NASDAQ:KMTS – Free Report) in a research report sent to investors on Wednesday,Benzinga reports. They currently have a $32.00 price target on... More of this article »
Aldeyra Therapeutics (NASDAQ:ALDX) Receives “Neutral” Rating from HC Wainwright
HC Wainwright restated their neutral rating on shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) in a research note issued to investors on Wednesday morning, Marketbeat reports. They currently have a $2.00 target price... More of this article »
Duolingo (NASDAQ:DUOL) Receives “Hold” Rating from Argus
Argus reiterated their hold rating on shares of Duolingo (NASDAQ:DUOL – Free Report) in a report published on Wednesday, MarketBeat reports. Several other research analysts have also issued reports on the stock. Bank of America... More of this article »